Bluejay Diagnostics implements 1-for-4 reverse stock split effective Jan 29, 2026

Bluejay Diagnostics, Inc.

Reverse stock split at 1-for-4 ratio; outstanding shares reduced from ~2,834,133 to ~708,533.
Shares from prefunded warrants reduced from 1,055,000 to 263,750; no fractional shares issued.
Common stock continues trading under symbol 'BJDX' on Nasdaq; new CUSIP 095633608.
Board approved final ratio on Jan 27, 2026; Certificate of Amendment filed with Delaware.

item 3.03item 5.03item 5.07item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.